Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Molecular Basis for Drug Resistance in HIV-1 Protease.

Ali A, Bandaranayake RM, Cai Y, King NM, Kolli M, Mittal S, Murzycki JF, Nalam MN, Nalivaika EA, Ozen A, Prabu-Jeyabalan MM, Thayer K, Schiffer CA.

Viruses. 2010 Nov;2(11):2509-35. doi: 10.3390/v2112509.

PMID:
21994628
2.

Improving Viral Protease Inhibitors to Counter Drug Resistance.

Kurt Yilmaz N, Swanstrom R, Schiffer CA.

Trends Microbiol. 2016 Jul;24(7):547-57. doi: 10.1016/j.tim.2016.03.010. Review.

PMID:
27090931
3.

Is resistance futile?

Kutilek VD, Sheeter DA, Elder JH, Torbett BE.

Curr Drug Targets Infect Disord. 2003 Dec;3(4):295-309. Review.

PMID:
14754431
4.

A hierarchical model of HIV-1 protease drug resistance.

Goodsell DS.

Appl Bioinformatics. 2002;1(1):3-12. Review.

PMID:
15130852
5.

Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design.

Velazquez-Campoy A, Muzammil S, Ohtaka H, Schön A, Vega S, Freire E.

Curr Drug Targets Infect Disord. 2003 Dec;3(4):311-28. Review.

PMID:
14754432
6.

Saquinavir. Clinical pharmacology and efficacy.

Vella S, Floridia M.

Clin Pharmacokinet. 1998 Mar;34(3):189-201. Review.

PMID:
9533981
7.

Human Immunodeficiency Virus Gag and protease: partners in resistance.

Fun A, Wensing AM, Verheyen J, Nijhuis M.

Retrovirology. 2012 Aug 6;9:63. doi: 10.1186/1742-4690-9-63. Review.

PMID:
22867298
8.

Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.

Soriano V, de Mendoza C.

HIV Clin Trials. 2002 May-Jun;3(3):249-57. Review.

PMID:
12032884
9.

Enhancing protein backbone binding--a fruitful concept for combating drug-resistant HIV.

Ghosh AK, Anderson DD, Weber IT, Mitsuya H.

Angew Chem Int Ed Engl. 2012 Feb 20;51(8):1778-802. doi: 10.1002/anie.201102762. Review.

PMID:
22290878
10.

Hepatitis C virus resistance to protease inhibitors.

Halfon P, Locarnini S.

J Hepatol. 2011 Jul;55(1):192-206. doi: 10.1016/j.jhep.2011.01.011. Review.

PMID:
21284949
11.

Recent developments of peptidomimetic HIV-1 protease inhibitors.

Qiu X, Liu ZP.

Curr Med Chem. 2011;18(29):4513-37. Review.

PMID:
21864279
12.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
13.

Defining HIV-1 protease substrate selectivity.

Beck ZQ, Morris GM, Elder JH.

Curr Drug Targets Infect Disord. 2002 Mar;2(1):37-50. Review.

PMID:
12462152
14.

Resistance to HIV protease inhibitors: mechanisms and clinical consequences.

de Mendoza C, Soriano V.

Curr Drug Metab. 2004 Aug;5(4):321-8. Review.

PMID:
15320704
Items per page

Supplemental Content

Support Center